한글목차

2024년부터 2031년까지 예측 기간 동안 6.1%의 연평균 성장률(CAGR)로 2024년에 275억 3,000만 달러로 평가된 세계 유아 임상 영양 시장 규모는 출산율 증가, 소비자 인식 증가, 영양 과학의 발전에 힘입어 2031년까지 416억 8,000만 달러에 달할 것으로 예상됩니다.

유아 임상 영양 제품에 대한 수요는 영유아의 건강에 대한 인식이 높아지고 미숙아 출산이 증가함에 따라 증가하는 추세입니다. 세계보건기구(WHO)에 따르면, 매년 1,500만 명 이상의 조산아들이 태어나고 있어 영양이 풍부한 보충제의 필요성이 강조되고 있습니다. 이에 따라 우유 기반, 콩 기반, 유기농, 프로바이오틱스/프리바이오틱스 제품 등 제품 제형의 혁신이 시장 성장의 원동력이 되고 있습니다.

세계의 출산율은 특히 개발도상국에서 증가하고 있으며, 이는 영유아 영양 제품에 대한 수요 증가로 이어지고 있습니다. 정부 및 의료 기관은 조산 예후를 개선하기 위해 적극적으로 노력하고 있으며, 이는 시장을 더욱 촉진하고 있습니다.

이 보고서는 세계 유아 임상 영양 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 투여 경로별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 유아 임상 영양 시장 전망, 2019-2031년

• 세계의 유아 임상 영양 시장 전망, 제품 유형별, 금액(10억 달러), 2019-2031년
• 세계의 유아 임상 영양 시장 전망, 투여 경로별, 금액(10억 달러), 2019-2031년
• 세계의 유아 임상 영양 시장 전망, 지역별, 금액(10억 달러), 2019-2031년

제4장 북미의 유아 임상 영양 시장 전망, 2019-2031년

제5장 유럽의 유아 임상 영양 시장 전망, 2019-2031년

제6장 아시아태평양의 유아 임상 영양 시장 전망, 2019-2031년

제7장 라틴아메리카의 유아 임상 영양 시장 전망, 2019-2031년

제8장 중동 및 아프리카의 유아 임상 영양 시장 전망, 2019-2031년

제9장 경쟁 상황

• 제품 유형과 투여 경로별 히트맵
• 기업 시장 점유율 분석, 2024년
• 경쟁 대시보드
• 기업 개요
  • Abbott Laboratories
  • Baxter International Inc.
  • Nestle S.A.
  • Danone
  • Meiji Holdings Co., Ltd.,
  • Fresenius SE & Co. KGaA
  • Reckitt Benckiser Group Plc
  • Perrigo Co. Plc
  • Ingredion Inc.
  • Solace Nutrition

제10장 부록

영문목차

The global infant clinical nutrition market is projected to expand at a CAGR of 6.1% during the forecast period from 2024 to 2031. Valued at US$ 27.53 billion in 2024, the market is expected to reach US$ 41.68 billion by 2031, fueled by increasing birth rates, rising consumer awareness, and advancements in nutritional science.

The demand for infant clinical nutrition products is on the rise due to growing awareness of infant health needs and the prevalence of premature births. According to the World Health Organization (WHO), more than 15 million preterm babies are born annually, emphasizing the need for nutrition-rich supplements. As a result, innovations in product formulations, including milk-based, soy-based, organic, and probiotic/prebiotic products, are driving market growth.

Key Market Drivers

1.Increasing Birth Rates and Premature Births:

• Global birth rates are rising, particularly in developing nations, creating an increased demand for infant nutritional products.
• Governments and healthcare organizations are actively working to improve the outcomes of preterm births, further boosting the market.

2.Consumer Awareness and Lifestyle Changes:

• With rising female labor force participation, dual-income households are increasingly investing in premium nutritional products for their infants.
• Growing awareness about infant health needs and nutritional supplements is driving the demand for high-quality products.

3.Demand for Premium Products:

• Parents are willing to spend more on premium-quality infant nutrition products due to improved purchasing power and heightened health consciousness.

4.Technological Advancements:

• Continuous research in biotechnology is enabling manufacturers to develop specialized products that cater to diverse nutritional needs, improving metabolic and developmental outcomes.

Opportunities in the Market

1.Innovation in Product Development:

• Manufacturers are focusing on developing advanced formulations, including organic and probiotic-based products, to meet specific infant needs.
• Incorporation of cutting-edge technologies and neonatal care research is paving the way for more effective nutritional solutions.

2.Geographical Expansion:

• Emerging markets in South Asia, East Asia, and Africa are becoming key areas of growth due to rising birth rates and increased awareness of infant health.

3.Strategic Investments:

• Multinational players are heavily investing in research, branding, and supply chain optimization to strengthen their market position.

Challenges Facing the Market

Stringent regulations from authorities such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) impose strict quality standards. Manufacturers must comply with nutrient specifications and labeling requirements, often resulting in prolonged approval procedures and higher production costs.

Regional Insights

North America:

• North America is a prominent region in the infant clinical nutrition market, driven by advancements in food nutrition.
• The increasing adoption of clean-label trends significantly contributes to the region's market growth.

Europe:

• Europe plays a key role in the market, with a growing preference for premium-quality infant nutrition products.
• Capital investments in the food sector and rising consumer awareness about nutritional supplements are major growth factors.

Asia-Pacific:

• Asia-Pacific is emerging as the fastest-growing region in the infant clinical nutrition market.
• Population growth and improvements in healthcare infrastructure are key drivers boosting market expansion in this region.

Competitive Analysis

The infant clinical nutrition market is highly competitive, with multinational players dominating the landscape. Companies are focusing on R&D, branding, and innovative product launches to attract new customers and retain existing ones.

Key Players Include:

• Abbott Laboratories
• Baxter International
• Nestle S.A.
• Danone
• Meiji Holdings Co., Ltd.
• Fresenius SE & Co. KGaA
• Reckitt Benckiser Group Plc
• Perrigo Co. Plc
• Ingredion Inc.
• Solace Nutrition

These companies are leveraging advanced technologies and efficient production processes to enhance product offerings and meet rising consumer demands.

Infant Clinical Nutrition Market Segmentation

1.By Product Type:

• Milk-Based
• Soy-Based
• Organic
• Probiotic/Prebiotic

2.By Route of Administration:

• Oral Administration
• Enteral Administration
• Intravenous Administration

3.By Region:

• North America
• Latin America
• Europe
• South Asia & Pacific
• East Asia
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Infant Clinical Nutrition Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Infant Clinical Nutrition Market Outlook, 2019 - 2031

• 3.1. Global Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. Milk-Based
    • 3.1.1.2. Soy-Based
    • 3.1.1.3. Organic
    • 3.1.1.4. Probiotic/Prebiotic
• 3.2. Global Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Oral administration
    • 3.2.1.2. Enteral administration
    • 3.2.1.3. Intravenous administration
• 3.3. Global Infant Clinical Nutrition Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. North America
    • 3.3.1.2. Europe
    • 3.3.1.3. Asia Pacific
    • 3.3.1.4. Latin America
    • 3.3.1.5. Middle East & Africa

4. North America Infant Clinical Nutrition Market Outlook, 2019 - 2031

• 4.1. North America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Milk-Based
    • 4.1.1.2. Soy-Based
    • 4.1.1.3. Organic
    • 4.1.1.4. Probiotic/Prebiotic
• 4.2. North America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Oral administration
    • 4.2.1.2. Enteral administration
    • 4.2.1.3. Intravenous administration
  • 4.2.2. BPS Analysis/Market Attractiveness Analysis
• 4.3. North America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. U.S. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 4.3.1.2. U.S. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 4.3.1.3. Canada Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 4.3.1.4. Canada Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Infant Clinical Nutrition Market Outlook, 2019 - 2031

• 5.1. Europe Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Milk-Based
    • 5.1.1.2. Soy-Based
    • 5.1.1.3. Organic
    • 5.1.1.4. Probiotic/Prebiotic
• 5.2. Europe Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Oral administration
    • 5.2.1.2. Enteral administration
    • 5.2.1.3. Intravenous administration
  • 5.2.2. BPS Analysis/Market Attractiveness Analysis
• 5.3. Europe Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Germany Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.3.1.2. Germany Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.1.3. U.K. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.3.1.4. U.K. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.1.5. France Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.3.1.6. France Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.1.7. Italy Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.3.1.8. Italy Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.1.9. Turkey Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.3.1.10. Turkey Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.1.11. Russia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.3.1.12. Russia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.1.13. Rest of Europe Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.3.1.14. Rest of Europe Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Infant Clinical Nutrition Market Outlook, 2019 - 2031

• 6.1. Asia Pacific Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Milk-Based
    • 6.1.1.2. Soy-Based
    • 6.1.1.3. Organic
    • 6.1.1.4. Probiotic/Prebiotic
• 6.2. Asia Pacific Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Oral administration
    • 6.2.1.2. Enteral administration
    • 6.2.1.3. Intravenous administration
  • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
• 6.3. Asia Pacific Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. China Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.3.1.2. China Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.1.3. Japan Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.3.1.4. Japan Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.1.5. South Korea Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.3.1.6. South Korea Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.1.7. India Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.3.1.8. India Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.1.9. Southeast Asia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.3.1.10. Southeast Asia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.1.11. Rest of Asia Pacific Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.3.1.12. Rest of Asia Pacific Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Infant Clinical Nutrition Market Outlook, 2019 - 2031

• 7.1. Latin America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. Milk-Based
    • 7.1.1.2. Soy-Based
    • 7.1.1.3. Organic
    • 7.1.1.4. Probiotic/Prebiotic
• 7.2. Latin America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 7.2.1. Key Highlights
    • 7.2.1.1. Oral administration
    • 7.2.1.2. Enteral administration
    • 7.2.1.3. Intravenous administration
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Latin America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Brazil Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 7.3.1.2. Brazil Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.3.1.3. Mexico Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 7.3.1.4. Mexico Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.3.1.5. Argentina Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 7.3.1.6. Argentina Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.3.1.7. Rest of Latin America Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 7.3.1.8. Rest of Latin America Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Infant Clinical Nutrition Market Outlook, 2019 - 2031

• 8.1. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. Milk-Based
    • 8.1.1.2. Soy-Based
    • 8.1.1.3. Organic
    • 8.1.1.4. Probiotic/Prebiotic
• 8.2. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Oral administration
    • 8.2.1.2. Enteral administration
    • 8.2.1.3. Intravenous administration
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. GCC Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.3.1.2. GCC Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.3.1.3. South Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.3.1.4. South Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.3.1.5. Egypt Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.3.1.6. Egypt Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.3.1.7. Nigeria Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.3.1.8. Nigeria Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.3.1.9. Rest of Middle East & Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.3.1.10. Rest of Middle East & Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Product Type vs by Route of Administration Heatmap
• 9.2. Company Market Share Analysis, 2024
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Abbott Laboratories
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Development
  • 9.4.2. Baxter International Inc.
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Product Portfolio
    • 9.4.2.3. Financial Overview
    • 9.4.2.4. Business Strategies and Development
  • 9.4.3. Nestle S.A.
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Product Portfolio
    • 9.4.3.3. Financial Overview
    • 9.4.3.4. Business Strategies and Development
  • 9.4.4. Danone
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Product Portfolio
    • 9.4.4.3. Financial Overview
    • 9.4.4.4. Business Strategies and Development
  • 9.4.5. Meiji Holdings Co., Ltd.,
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Product Portfolio
    • 9.4.5.3. Financial Overview
    • 9.4.5.4. Business Strategies and Development
  • 9.4.6. Fresenius SE & Co. KGaA
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Product Portfolio
    • 9.4.6.3. Financial Overview
    • 9.4.6.4. Business Strategies and Development
  • 9.4.7. Reckitt Benckiser Group Plc
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Product Portfolio
    • 9.4.7.3. Financial Overview
    • 9.4.7.4. Business Strategies and Development
  • 9.4.8. Perrigo Co. Plc
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Product Portfolio
    • 9.4.8.3. Financial Overview
    • 9.4.8.4. Business Strategies and Development
  • 9.4.9. Ingredion Inc.
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Product Portfolio
    • 9.4.9.3. Financial Overview
    • 9.4.9.4. Business Strategies and Development
  • 9.4.10. Solace Nutrition
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Product Portfolio
    • 9.4.10.3. Financial Overview
    • 9.4.10.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations